These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 3264604
1. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies. Marongiu ME, Piccardi MP, Bernardi F, Corsini GU, Del Zompo M. Neurosci Lett; 1988 Dec 05; 94(3):349-54. PubMed ID: 3264604 [Abstract] [Full Text] [Related]
5. Metabolism of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a rat pheochromocytoma cell line, PC12h. Naoi M, Takahashi T, Nagatsu T. Life Sci; 1987 Dec 14; 41(24):2655-61. PubMed ID: 3121966 [Abstract] [Full Text] [Related]
6. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC. Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685 [Abstract] [Full Text] [Related]
7. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ, Heavens RP, McBride CS. Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784 [Abstract] [Full Text] [Related]
8. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+. Nakamura S, Vincent SR. Neurosci Lett; 1986 Apr 24; 65(3):321-5. PubMed ID: 3487052 [Abstract] [Full Text] [Related]
9. Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes. Di Monte D, Ekström G, Shinka T, Smith MT, Trevor AJ, Castagnoli N. Chem Biol Interact; 1987 Apr 24; 62(2):105-16. PubMed ID: 3496169 [Abstract] [Full Text] [Related]
13. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Ransom BR, Kunis DM, Irwin I, Langston JW. Neurosci Lett; 1987 Apr 10; 75(3):323-8. PubMed ID: 3495754 [Abstract] [Full Text] [Related]
14. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine. Kindt MV, Heikkila RE, Nicklas WJ. J Pharmacol Exp Ther; 1987 Sep 10; 242(3):858-63. PubMed ID: 3498818 [Abstract] [Full Text] [Related]
15. MPTP, MPP+ and mitochondrial function. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE. Life Sci; 1987 Feb 23; 40(8):721-9. PubMed ID: 3100899 [Abstract] [Full Text] [Related]
16. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation. Fonck C, Baudry M. Brain Res; 2001 Jun 29; 905(1-2):199-206. PubMed ID: 11423095 [Abstract] [Full Text] [Related]
17. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity. Kinemuchi H, Arai Y, Toyoshima Y. Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524 [Abstract] [Full Text] [Related]
18. The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles. Sokol PP, Holohan PD, Ross CR. J Pharmacol Exp Ther; 1987 Jul 31; 242(1):152-7. PubMed ID: 2956410 [Abstract] [Full Text] [Related]
19. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. Shen RS, Abell CW, Gessner W, Brossi A. FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242 [Abstract] [Full Text] [Related]
20. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Mytilineou C, Cohen G. J Neurochem; 1985 Dec 23; 45(6):1951-3. PubMed ID: 3932598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]